349 related articles for article (PubMed ID: 24390518)
1. Clinical and radiological observations in a case series of 26 patients with fibrous dysplasia.
Thomsen MD; Rejnmark L
Calcif Tissue Int; 2014 Apr; 94(4):384-95. PubMed ID: 24390518
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Long-Term Bisphosphonate Therapy in McCune-Albright Syndrome and Polyostotic Fibrous Dysplasia.
Majoor BC; Appelman-Dijkstra NM; Fiocco M; van de Sande MA; Dijkstra PS; Hamdy NA
J Bone Miner Res; 2017 Feb; 32(2):264-276. PubMed ID: 27649526
[TBL] [Abstract][Full Text] [Related]
3. Fracture incidence in polyostotic fibrous dysplasia and the McCune-Albright syndrome.
Leet AI; Chebli C; Kushner H; Chen CC; Kelly MH; Brillante BA; Robey PG; Bianco P; Wientroub S; Collins MT
J Bone Miner Res; 2004 Apr; 19(4):571-7. PubMed ID: 15005844
[TBL] [Abstract][Full Text] [Related]
4. Fibrous dysplasia & McCune-Albright syndrome: an experience from a tertiary care centre in north India.
Bhadada SK; Bhansali A; Das S; Singh R; Sen R; Agarwal A; Mittal BR; Nahar U; Dutta P; Khandelwal N
Indian J Med Res; 2011 May; 133(5):504-9. PubMed ID: 21623035
[TBL] [Abstract][Full Text] [Related]
5. Polyostotic Fibrous Dysplasia With and Without McCune-Albright Syndrome-Clinical Features in a Nordic Pediatric Cohort.
Utriainen P; Valta H; Björnsdottir S; Mäkitie O; Horemuzova E
Front Endocrinol (Lausanne); 2018; 9():96. PubMed ID: 29599748
[TBL] [Abstract][Full Text] [Related]
6. Lesion Expansion in Gnathic Fibrous Dysplasia: Natural History, Indicators of Progression, and Response to Bisphosphonates.
Pan KS; Taylor J; Szymczuk V; Boyce AM
J Bone Miner Res; 2023 Oct; 38(10):1465-1471. PubMed ID: 37477421
[TBL] [Abstract][Full Text] [Related]
7. EFFICACY AND SAFETY OF BISPHOSPHONATE THERAPY IN MCCUNE-ALBRIGHT SYNDROME-RELATED POLYOSTOTIC FIBROUS DYSPLASIA: A SINGLE-CENTER EXPERIENCE.
Wang Y; Wang O; Jiang Y; Li M; Xia W; Meng X; Xing X
Endocr Pract; 2019 Jan; 25(1):23-30. PubMed ID: 30383490
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic journey for individuals with fibrous dysplasia / McCune albright syndrome (FD/MAS).
Song K; Shrestha R; Delaney H; Vijjhalwar R; Turner A; Sanchez M; Javaid MK
Orphanet J Rare Dis; 2024 Feb; 19(1):50. PubMed ID: 38326833
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological Interventions Targeting Pain in Fibrous Dysplasia/McCune-Albright Syndrome.
Tucker-Bartley A; Selen DJ; Golden E; van Gool R; Ebb D; Mannstadt M; Upadhyay J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768871
[TBL] [Abstract][Full Text] [Related]
10. McCune-Albright syndrome.
Dumitrescu CE; Collins MT
Orphanet J Rare Dis; 2008 May; 3():12. PubMed ID: 18489744
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Factors From an Epidemiologic Evaluation of Fibrous Dysplasia of Bone in a Modern Cohort: The FRANCEDYS Study.
Benhamou J; Gensburger D; Messiaen C; Chapurlat R
J Bone Miner Res; 2016 Dec; 31(12):2167-2172. PubMed ID: 27340799
[TBL] [Abstract][Full Text] [Related]
12. [A case of polyostotic fibrous dysplasia].
Klempous J; Kuźniar J; Sztuka A; Jaworska M
Wiad Lek; 2006; 59(1-2):125-7. PubMed ID: 16646308
[TBL] [Abstract][Full Text] [Related]
13. McCune-Albright syndrome onset with vaginal bleeding.
Van Doan N; Minh Duc N; Kim Ngan V; Van Anh N
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34281944
[TBL] [Abstract][Full Text] [Related]
14. Difficulties in diagnosis and treatment of acromegaly in a patient with a McCune-Albright syndrome. A case report and a review of literature.
Baszko-Błaszyk D; Slynko J; Liebert W; Sosnowski P; Sowiński J; Waśko R
Neuro Endocrinol Lett; 2010; 31(5):594-6. PubMed ID: 21173751
[TBL] [Abstract][Full Text] [Related]
15. Extent of Extraskeletal Manifestations of Fibrous Dysplasia/McCune-Albright Syndrome in Patients with Mazabraud's Syndrome.
Hagelstein-Rotman M; Appelman-Dijkstra NM; Boyce AM; Chapurlat R; Dur NBJ; Gensburger D; Majoor BCJ; van de Sande MAJ; Dijkstra PDS
Calcif Tissue Int; 2022 Mar; 110(3):334-340. PubMed ID: 34854944
[TBL] [Abstract][Full Text] [Related]
16. Early fractures and occult hyperthyroidism: McCune-Albright syndrome?
Di Candia S; Weber G; Mora S; de Pellegrin M; Chiumello G
Horm Res; 2001; 56(1-2):58-62. PubMed ID: 11815729
[TBL] [Abstract][Full Text] [Related]
17. [Clinicopathological analysis of 105 patients with fibrous dysplasia of cranio-maxillofacial region].
Xue J; Zhang JY; Shi RR; Xie XY; Bai JY; Li TJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 54(1):54-61. PubMed ID: 35165468
[TBL] [Abstract][Full Text] [Related]
18. Fibrous dysplasia of bone: craniofacial and dental implications.
Burke AB; Collins MT; Boyce AM
Oral Dis; 2017 Sep; 23(6):697-708. PubMed ID: 27493082
[TBL] [Abstract][Full Text] [Related]
19. Fibrous dysplasia of bone and McCune-Albright syndrome.
Chapurlat RD; Orcel P
Best Pract Res Clin Rheumatol; 2008 Mar; 22(1):55-69. PubMed ID: 18328981
[TBL] [Abstract][Full Text] [Related]
20. Odontoiatric perspectives and osteonecrosis of the jaw as a possible adverse effect of bisphosphonates therapy in fibrous dysplasia and McCune-Albright syndrome.
Tessaris D; Matarazzo P; Lala R; Defabianis P
J Pediatr Endocrinol Metab; 2016 Mar; 29(3):333-6. PubMed ID: 26565547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
